Cancer mortality rates in the United States have dropped, according to a new ACS report.
A twenty percent decrease in cancer death rate among children and adolescents has taken place from 1999 to 2014.
Low aerobic capacity has greater effect on longevity than even high cholesterol, or high blood pressure.
A study of nearly 1000 patients with HCC found that black patients with the disease had a 33% greater risk of death compared with non-Hispanic whites.
Research indicates that four key lifestyle factors contribute significantly to cancer mortality outcomes.
Previous Cancers Linked to Higher Rates for Death and New Cancers in Organ Transplantation RecipientsMay 06, 2016
People who had had cancer before an organ transplant are more likely to die of any cause or of cancer, or to develop a new cancer than people had not had cancer before an organ transplant.
The cancer death rate has dropped by 23% since its peak in 1991, averting more than 1.7 million cancer deaths through 2012, with advances in cancer prevention, early detection, and treatment a part of this rate decline.
Mortality rate changes in the United States since 1991 translate to an additional 1.7 million cancer survivors.
Cancer patients in their last weeks of life may have end-of-life experiences, including dreams and visions. A study from researchers at a hospice found that these events are an important part of a patient's dying process.
Cancer mortality in solid-organ transplant recipients (SOTRs) was increased compared with the cancer death rate expected in the general population.
More than 3 months from surgery to chemotherapy and increasing delays from diagnosis to surgery in patients with breast cancer are associated with increased risk of death from the disease.
Researchers estimate the 20-year breast cancer-specific death rate for women diagnosed with ductal carcinoma in situ to be 3.3%.
African American men are more likely to develop prostate cancer than European American men, and are also more than twice as likely to die from it.
Areas of the U.S. with higher colorectal cancer rates include parts of the Mississippi Delta, Appalachia, and eastern Virginia.
Age-adjusted prostate cancer-specific comorbidity index is strongly predictive of other-cause mortality, according to recent study data.
HIV has been linked to increased risk for colorectal, lung, skin, and breast cancers, independent of treatment.
Eighty percent of lung cancer deaths linked to smoking, researchers say, and the mortality rate of several other cancers is also strongly impacted by smoking status.
Fewer childhood cancer survivors die of 'late effects' from radiation and chemotherapy, according to recent research.
Post-diagnostic aspirin use is not associated with a decreased risk of prostate cancer outcomes, according to study data.
Cigarette smoking doubles the mortality risk for colorectal cancer survivors.
Leading cancer killer of American women for many years
Focusing screening efforts on those with a positive family history of prostate cancer could be more effective.
A 22% decline in cancer mortality over two decades led to the avoidance of more than 1.5 million cancer deaths that would have occurred if peak rates had continued, according to the American Cancer Society.
Cause-specific mortality similar for women and girls with pregnancy-associated MM or non-PAMM.
In cases of bladder cancer, omission of muscle in specimen or its mention in pathology report is linked to increased mortality.
Even a small daily dose of aspirin may help lower mortality among men with nonmetastatic prostate cancer, according to research.
In a study of more than 1.1 million cancer patients who had surgery, almost 5 percent died within one month of their operation. Lack of access to quality care a major factor in these deaths, researchers say.
About 14.5 million U.S. cancer survivors are alive today, but aging population and increasing obesity threaten progress.
Patients with Medicaid insurance or no insurance coverage are less likely to receive cancer-related surgery and/or radiation and are more likely to die from cancer than those with insurance, according to an online study.
Prostate-specific antigen (PSA) screening is associated with a lasting reduction in prostate cancer mortality, according to a study published online.
- Ruxolitinib May Improve Symptom Control in Patients With CLL
- Obesity Increases Risk for Transformation of MGUS to Multiple Myeloma
- Racial Disparities Persist in Myeloma Treatment Use
- Adding Bortezomib to Rd Improves PFS, OS in Newly Diagnosed Myeloma
- Lutetium-177 Dotatate Improves PFS in Advanced Midgut Carcinoid Tumors
- Optimal Timing of Influenza Vaccination in Patients Receiving Chemotherapy
- Racial Disparities Persist in Myeloma Treatment Use
- Hypnosis and Its Use in Cancer Treatment
- Longer Dosing Interval of Zoledronic Acid May Be Acceptable for Bone Metastases
- Patients With Breast Cancer Report More Cognitive Difficulties After Chemotherapy
- No Differences in Lung Cancer Mutations Between White, Black Patients
- Second-line Weekly Nab-paclitaxel Noninferior to Paclitaxel for Gastric Cancer
- Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
- Role of Oncology Nurse Navigators Has Evolved and Expanded in 5 Years
- Frailty Classifications Associated With Prognosis Among Older Patients
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|